Delivery Order SPE2DB24D3015-SPE2DB24FFXPF

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML medication. The firm-fixed-price contract, valued at $1,187.60, has an ultimate completion date of July 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,068.84 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medication used to treat diabetes. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $2,733.44 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to support government healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA,...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML at a ceiling value of $1,628.55. The contract has a performance period through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC, designated as SPE2DX,...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The contract has a potential value of $1,187.60 and a completion date of March 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,535.60, is for the procurement of 4563589249 LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, with a completion date of February 8, 2024. This delivery order is issued under an...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceuticals. The contract has a potential value of $1,275.07 and a completion date of January 29, 2024. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,758.99 to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical company AmerisourceBergen Corporation. The contract is for the provision of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product, in support of military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order (SPE2DB22D1103|SPE2DB24FTHR0) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,423.25 contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription medication, to support military treatment programs and facilities. The contract has an ultimate completion date of April 8, 2024. This delivery order is part of a...
The U.S. government awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply LANTUS SOLOSTAR 100 UNIT/ML 3ML medication. The contract, valued at $1,635.15, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of April 22, 2024. Amerisourcebergen is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB24FFXPF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,654.42 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which covers a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by September 4, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain to provide essential medications and medical supplies to various federal agencies and healthcare programs.

Generated 12/3/24, 10:08 AM